Moneycontrol
SENSEX NIFTY
you are here:

Metropolis Healthcare Ltd.

BSE: 542650 | NSE: METROPOLIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE112L01020 | SECTOR: Hospitals & Medical Services

BSE Live

Jul 10, 15:52
1480.50 21.25 (1.46%)
Volume
AVERAGE VOLUME
5-Day
10,415
10-Day
70,009
30-Day
153,125
12,635
  • Prev. Close

    1459.25

  • Open Price

    1431.00

  • Bid Price (Qty.)

    1485.00 (10)

  • Offer Price (Qty.)

    1499.00 (100)

NSE Live

Jul 10, 15:45
1485.70 26.95 (1.85%)
Volume
AVERAGE VOLUME
5-Day
119,729
10-Day
151,611
30-Day
149,457
100,754
  • Prev. Close

    1458.75

  • Open Price

    1461.70

  • Bid Price (Qty.)

    1485.70 (502)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Metropolis

  • Jul 02, 2020 15:48 Source: NSE

    Metropolis Healthcare Limited

    Metropolis Healthcare Limited has informed the Exchange regarding 'Update on Acquisition of Shraddha Diagnostic Centre (I) Private Limited '.

  • Jul 02, 2020 15:18 Source: BSE

    Metropolis Healthcare - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    The Company vide letter dated 16th January, 2020 informed the Exchange(s) regarding the decision of Company to acquire 51% stake at a consideration of Rs.9,36,30,000/- in Shraddha Diagnostic Centre (I) Private Limited from its Promoters (Seller) vide Shareholders' Agreement and Share Purchase dated 16th January,2020 entered between the Company, SDCIPL and its promoters. The closure of transaction was subject, to certain conditions precedent as specified in the Share Purchase Agreement (SPA) to be fulfilled on or before the amended long stop date, as per the supplemental share purchase agreement. The promoters of SDCIPL have conveyed that they cannot fulfil certain conditions precedent due to which the closing could not be completed, which is a breach of Warranty. Therefore, the promoters of SDCIPL have communicated to the Company their intent to terminate the said SPA and accordingly the proposed acquisition stands closed.

  • Jun 30, 2020 19:25 Source: BSE

    Metropolis Healthcare - Closure of Trading Window

    Dear Sir / Madam, This is to inform you that pursuant to the Company''s Code of Fair Disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prevention of Insider Trading) Regulations, 2015, as amended, the Trading window for dealing in securities of the Company by the Designated Persons of the Company and / or their immediate relatives will be closed with effect from July 1, 2020 and shall remain closed up to 48 ( Forty Eight ) hours after the declaration of the Financial Results of the Company for the quarter ended June 30, 2020. The date of the Board meeting for approval of financial results of the Company for the quarter ended June 30, 2020 shall be intimated in due course. This is for your information and records.

  • Jun 29, 2020 11:40 Source: BSE

    Metropolis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Dear Sir/Madam, Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that the Officials of the Company will be Meeting the Investor (participant) on June 30, 2020 via Tele/Video Conferencing, the details of which is given below: Day & Date: Tuesday, June 30, 2020 Host: JP Morgan Medium: Tele/Video Conferencing Kindly note that changes may happen due to exigencies on the part of Host / Company. We also wish to inform you that the copy of the Investor Update which shall be referred in the abovementioned meeting has already been uploaded on the website of the Company at www.metropolisindia.com and issued to the Stock Exchanges on May 29, 2020. This is for your information and also for the information of your members and the public at large.

  • Jun 27, 2020 22:54 Source: BSE

    Metropolis Healthcare - Submission Of Revised Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Dear Sir/Madam, This has reference to the Disclosure of Related Party Transactions for the half year ended 31st March,2020 made by us on June 26, 2020 having the reference no. MHL/Sec&Legal/2020-21/111 In this regard please find the enclosed herewith the revised disclosure of the Related Party Transactions on a Consolidated basis for the half year ended March 31, 2020 in the format prescribed in the relevant Accounting Standards as per Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The same will also be uploaded on the website of the Company at https://www.metropolisindia.com/.

  • Jun 26, 2020 16:55 Source: BSE

    Metropolis Healthcare - Disclosures Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions on a consolidated basis, prepared in accordance with applicable Accounting Standards for the half year ended March 31, 2020. The same will also be uploaded on the website of the Company at https://www.metropolisindia.com/. This is for your information and record.

  • Jun 26, 2020 16:38 Source: BSE

    Metropolis Healthcare - Compliances-Reg.24(A)-Annual Secretarial Compliance

    Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019; we are enclosing herewith the Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2020, issued by M/s. Manish Ghia & Associates, Practicing Company Secretaries. You are requested to kindly take the above information on record

  • Jun 26, 2020 14:10 Source: BSE

    Metropolis Healthcare - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Sushil Kanubhai Shah & Others

  • Jun 24, 2020 19:01 Source: BSE

    Metropolis Healthcare - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('Listing Regulations')

    This is to inform you that a member of the Promoter Group of the Company has divested 3,054,545 equity shares of the Company constituting 6.03% of the issued and paid-up share capital of the Company through a bulk deal transaction on the Stock Exchanges today.

  • Jun 21, 2020 21:02 Source: BSE

    Metropolis Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform that the Officials of the Company will be Meeting a Group of Investors (participants) on June 23, 2020 and June 24, 2020 via Tele/Video Conferencing.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : May 29, 2020
Remark : Audited Results